International Clinical Trial: A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07731139) titled 'A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity' on July 24.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Basic Science. Masking: Double (Participant, Investigator).

Primary Sponsor: Pfizer

Condition: Obesity

Intervention: Drug: PF-08642534

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: July 28, 2026

Target Sample Size: 120

Countries of Recruitment: United States

To know more, visit https://clinicaltrial...